medicine
Thursday April 13, 2023
Bethesda/Maryland – The increased risk of cardiovascular disease in HIV-infected people as a result of the disease can be significantly reduced by treatment with an appropriate statin. This is shown by the results of the randomized, controlled REPRIEVE study, which was terminated prematurely following an interim analysis, as the US National Institute of Allergy and Infectious Diseases has now announced. A publication…
